Erick Aybar receives cortisone shot in left knee

Leave a comment

Erick Aybar has been shut down until later this week after receiving a cortisone shot in his left knee on Tuesday, according to Mike DiGiovanna of the Los Angeles Times.

Aybar hasn’t played since suffering cartilage damage in his left knee on
a hard slide by Casey McGehee of the Brewers slide last Monday. The club will wait a few days to see how the knee responds to today’s shot, but it appears he’s headed for the disabled list. 

“We’re encouraged that long-range, it won’t be an issue,” Manager Mike
Scioscia said before the Angels’ game against the Dodgers. “But
short-range, we might shut him down and give him an extra week to get
ready.”

Aybar is batting .272/.336/.352 with one home run, 13 RBI, 11 stolen bases and 41 runs scored over his first 261 at-bats this season. Brandon Wood, who was activated from the disabled list last week, will continue to fill in at shortstop.
 

Angels’ Pujols has foot surgery, could be sidelined 4 months

pujols
Getty Images
Leave a comment

ANAHEIM, Calif. — Los Angeles Angels slugger Albert Pujols had surgery on his right foot Friday, possibly sidelining him past opening day.

Angels general manager Billy Eppler said Pujols had the procedure Friday in North Carolina to release his plantar fascia, the ligament connecting the heel to the toes. The three-time NL MVP was bothered by plantar fasciitis repeatedly during the season, but played through the pain in arguably the strongest year of his half-decade with the Angels.

Eppler said the surgery typically prevents players from participating in baseball activities for three months, along with another month before they’re ready to resume playing in games. Opening day for Los Angeles is April 3, and the Angels hope Pujols can be ready.

“He’s at that point in his career where he’s keenly aware of what’s happening with his body,” Eppler said in a phone interview. “I don’t put the timetable on Albert like you would with your younger players. We’ll just see in Albert’s case, as he progresses, what his timetable is.”

Pujols, who turns 37 next month, batted .268 last year with 31 homers and 119 RBIs, the fourth-most in the majors – although his .780 OPS was among the worst of his career. He largely served as a designated hitter instead of playing first base due to problems with his hamstrings and feet.

Pujols heads into 2017 with 591 career homers, ranking him ninth in major league history. He is 18 homers behind Sammy Sosa for eighth place.

After playing in pain until the final week of the Angels’ disappointing season, Pujols began shock wave therapy on his foot early in the offseason, believing he wouldn’t need surgery.

But Pujols’ foot became more painful in recent weeks despite the therapy, and he huddled with the Angels’ top brass to decide on surgery after his most recent trip to see Dr. Robert Anderson in North Carolina. Continuing with conservative care would have required 10 more weeks, forcing Pujols to miss the first half of the 2017 season if he still required surgery.

“He just felt that the pain had gotten to a point where he was comfortable” having surgery, Eppler said. “If we did delay it, you’re just looking at 2 1/2 more months into the season.”

Pujols had a different type of surgery on his right foot last winter, but recovered in time for opening day. He also had plantar fasciitis in his left foot during the 2013 season, eventually forcing him out for the year when his fascia snapped.

Pujols has five years and $140 million remaining on the 10-year, $240 million free-agent contract that pried him out of St. Louis, where he won two World Series and became a nine-time NL All-Star.

The Angels haven’t won a playoff game since Pujols’ arrival and Mike Trout‘s concurrent emergence as one of baseball’s best players. They went 74-88 last season, the injury-plagued club’s worst record since 1999.

Diamondbacks hire Mike Fitzgerald to head Research and Development department

BOSTON, MA - SEPTEMBER 24:  Mike Hazen, new Senior Vice President and General Manager of the Red Sox, addresses the media during a press conference to announce his promotion before the game against the Tampa Bay Rays at Fenway Park on September 24, 2015 in Boston, Massachusetts.  (Photo by Maddie Meyer/Getty Images)
Getty Images
Leave a comment

According to an official announcement, the Diamondbacks have acquired former Pirates quantitative analyst Mike Fitzgerald as their new Director of Research and Development.

Fitzgerald joined the Pirates’ front office in 2012, where he frequently accompanied the team on the road to help breach the divide between analytics and the clubhouse. According to a profile written by Grantland’s Ben Lindbergh in 2014, Fitzgerald’s multifaceted approach brought balance and perspective to the organization, whether he was assisting coaches in making statistically sound decisions, optimizing the batting order, weighing in on scouting and personnel decisions, developing more effective defensive positioning, or keeping players and personnel appraised of the latest developments in sabermetrics.

In the wake of Fitzgerald’s departure, Pirates’ GM Neal Huntington praised the Diamondbacks for a smart acquisition and said that the club has every intention of finding a replacement analyst, albeit one who will have some big shoes to fill.